HETEROZYGOUS BETA-THALASSEMIA - RELATIONSHIP BETWEEN THE HEMATOLOGICAL PHENOTYPE AND THE TYPE OF BETA-THALASSEMIA MUTATION

被引:34
作者
ROSATELLI, C
LEONI, GB
TUVERI, T
SCALAS, MT
MOSCA, A
GALANELLO, R
GASPERINI, D
CAO, A
机构
[1] UNIV CAGLIARI,IST CLIN & BIOL ETA EVOLUT,I-09100 CAGLIARI,ITALY
[2] BIOMED UNIV MILANO,DIPARTIMENTO SCI TECNOL,MILAN,ITALY
关键词
HETEROZYGOUS BETA-THALASSEMIA; BETA-THALASSEMIA MUTATIONS; HEMATOLOGICAL PHENOTYPE;
D O I
10.1002/ajh.2830390102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study we have correlated the severity of the hematological features to the type of the beta-thalassemia mutation [codon 39 (C --> T), IVS-I nt 110 (G --> A), IVS-I nt 1 (G --> A), IVS-I nt 6 (T --> C), IVS-II nt 745 (C --> G), -87 (C --> G) and beta-6 (-1bp)], in a group of beta-thalassemia heterozygotes of Italian descent in whom we excluded the presence of iron deficiency or deletion alpha-thalassemia. The beta-thalassemia mutation was defined by dot blot analysis on amplified DNA with allelic specific oligonucleotide probes. We found that a) heterozygotes for beta+ IVS-I nt 6 and beta+ -87 mutations produce larger and better hemoglobinized red blood cells, and b) heterozygotes for beta+IVS-I nt 6 and beta+IVS-I nt 110 mutations have a less marked increase of Hb A2 levels as compared to heterozygotes for the other mutations investigated. These findings indicate that milder beta-thalassemia mutations such as the beta+IVS-I nt 6 and beta+ -87, express also in the heterozygous state a milder phenotype as compared to beta-degrees-thalassemia or severe beta+ thalassemia (beta+ IVS-I, nt 110). The Hb A2 levels, on the other hand, were not related to the severity of the mutation because of less marked increase was found in a mild (beta+IVS-I nt 6) as well in a severe (beta+IVS-I nt 110) mutation. From the practical point of view these findings should be adequately considered in carrier screening and genetic counselling.
引用
收藏
页码:1 / 4
页数:4
相关论文
共 23 条
[1]  
CAO A, 1984, CLIN GENET, V26, P12
[2]  
Cao A, 1990, EUR J INTERN MED, V1, P227
[3]   A BETA-THALASSEMIA LESION ABOLISHES THE SAME MST-II SITE AS THE SICKLE MUTATION [J].
CHANG, JC ;
ALBERTI, A ;
KAN, YW .
NUCLEIC ACIDS RESEARCH, 1983, 11 (22) :7789-7794
[4]  
CODRINGTON JF, 1990, BLOOD, V76, P1246
[5]  
Goossens M, 1981, Methods Enzymol, V76, P805
[6]  
GURGEY A, 1987, BLOOD, V70, P159
[7]  
HUISMAN THJ, 1975, J LAB CLIN MED, V86, P700
[8]   THE INTERACTION OF ALPHA-THALASSEMIA WITH HETEROZYGOUS BETA-THALASSEMIA [J].
KANAVAKIS, E ;
WAINSCOAT, JS ;
WOOD, WG ;
WEATHERALL, DJ ;
CAO, A ;
FURBETTA, M ;
GALANELLO, R ;
GEORGIOU, D ;
SOPHOCLEOUS, T .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 52 (03) :465-473
[9]  
KAZAZIAN HH, 1983, AM J HUM GENET, V35, P1028
[10]  
LAUBER K, 1965, Z KLIN CHEM KLIN BIO, V3, P96